Could This Be the First Disease-Modifying Drug in Bronchiectasis?

(MedPage Today) — CHICAGO — Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial showed.
At the 25-mg dose…